Response to reintroduction of cetuximab in 5 patients with advanced, chemotherapy-resistant, colorectal cancer without progressive disease following first-line therapy with a cetuximab-containing regimen.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples